Thursday, April 27, four experts including MAPS founder Rick Doblin and former US drug policy advisor Kevin Sabet debate the merits of psychedelic reform
The Neuroscape Psychedelics Division is kicking off after receiving US$6.4 million in private funding to further psychedelic treatment for mental health